Actively Recruiting
Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF
Led by University of British Columbia · Updated on 2022-01-20
500
Participants Needed
2
Research Sites
321 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study intends to investigate health trends and data in cystic fibrosis patients all across Canada that are receiving modulator treatment so researchers can determine if CFTR treatments are effective over a long period of time and if so, which treatments work best for each individual. The study will collect clinical data from routine standard of care, patient reported outcomes via survey data and samples for a biobank.
CONDITIONS
Official Title
Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Prescribed a CFTR modulator therapy and planning to start modulator therapy within 30 days or planning to switch modulator therapies within 30 days
- Participates in the Canadian Cystic Fibrosis Registry (CCFR)
- Provides informed consent by participant, parent, legal guardian, or assent
You will not qualify if you...
- Known contraindications to CFTR modulator therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
British Columbia Children's Hospital
Vancouver, British Columbia, Canada, V6H 3N1
Actively Recruiting
2
St Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
Actively Recruiting
Research Team
A
Alam Lakhani
CONTACT
B
Britney Ha
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here